ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2210

Effects of Anti-Citrullinated Peptide Antibody (ACPA) on Bone Microstructure in Rheumatoid Arthritis: A HR-pQCT Study

Ikuko Tanaka1, Takashi Kato2, Motokazu Kai3, Kunikazu Ogawa3, Hiroaki Mizuno1, Mari Ushikubo4, Keisuke Izumi5, Hisaji Oshima6 and Shigenori Tamaki1, 1Nagoya Rheumatology Clinic, Nagoya, Japan, 2Department of Radiology, National Center for Geratrics and Gerontology, Obu, Japan, 3Mie Rheumatology Clinic, Suzuka, Japan, 4National Tokyo Medical Center, Tokyo, Japan, 5Department of connective Tissue Disease, National Tokyo Medical Center, Tokyo, Japan, 6Department of Connective Tissue Diseases, National Tokyo Medical Center, Tokyo, Japan

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: ACPA, arthritis and osteoporosis, Bone, HR-pQCT

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, October 23, 2018

Title: Imaging of Rheumatic Diseases Poster III: Other Modalities

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Rheumatoid arthritis (RA) induces systemic osteoporosis as well as osteoporotic change in the bones having arthritis by RA. Recently immune complex and anti-citrullinated peptide antibody (ACPA) in the blood of patients with RA have been reported to promote bone absorption through activating osteoclast directly (Negishi-Koga T. Nat Commun 2015, Harre U. J Clin Invest 2012). Bone absorption by ACPA is mainly observed in the trabecular bone of the cancellous bone (Lundberg K. Ann Rheum Dis 2016). In the present study, we investigated the effects of ACPA on bone microstructure of the distal radius in the patients with RA using high-resolution peripheral quantitative computed tomography (HR-pQCT).

Methods:

Subjects were 95 female patients with DMARDs naïve rheumatoid arthritis without bone erosion (N-group) and 14 female patients with primary osteoporosis (OP-group). The N-group was classified into 52 APCA-negative patients (NN-group, 59±2 y.o.) and 43 APCA-positive patients (PN-group, 58±2 y.o.). For subgroup analyses, 29 subjects in NN-group and 14 subjects in PN-group were selected with excluding active synovitis based on the ultrasonographic findings of the wrist and finger joints. All the patients underwent HR-pQCT in Nagoya Rheumatology Clinic. The bone microstructural parameters to be studied were Tt.vBMD(Total volumetric Bone Mineral Density), Ct(Cortical).vBMD, Tb(Trabecular).vBMD, Tb.Meta.vBMD, Tb.Inn(Inner).vBMD, Tb.N(the number of trabecula), Tb.Th(Thickness), Tb.Sp(Separation), Ct.Th(Thickness), Ct.Po(Porosity), and Ct.PoDm(Pore Diameter).

Results:

Significant difference (p<0.05) was observed in averaged left and right Ct.Po (cortical porosity) between NN-group (0.006±0.001) and PN-group (0.010±0.001). In NN-group, the parameters negatively correlated with age were Tt.vBMD, Ct.vBMD, Tb.vBMD, Tb.Meta.vBMD, Tb.Inn.vBMD, Tb.N, and Ct.Th, whereas positively correlated parameters were Ct.Po and Ct.PoDm. PN-group differed from NN-group only in that no significant negative correlation was observed in Tb.Inn.vBMD and Tb.N. These results suggested that ACPA affects the number of trabecula beyond the age-related change. The subgroup analyses excluding the effect of active synovitis represented that the difference between left and right Tb.N was significantly larger in PN-group (0.154±0.057/mm) than in NN-group (0.070±0.014/mm) and OP-group (0.056±0.037/mm) (p<0.05). The results mean ACPA have an left-right asymmetrical effect on the trabecular structure in the distal radius without relation to synovitis, while the pathophysiological mechanisms are not clear.

Conclusion:

The results suggested that APCA affects trabecular structure in patients with rheumatoid arthritis independent from the activity of synovitis.


Disclosure: I. Tanaka, None; T. Kato, None; M. Kai, None; K. Ogawa, None; H. Mizuno, None; M. Ushikubo, None; K. Izumi, None; H. Oshima, None; S. Tamaki, None.

To cite this abstract in AMA style:

Tanaka I, Kato T, Kai M, Ogawa K, Mizuno H, Ushikubo M, Izumi K, Oshima H, Tamaki S. Effects of Anti-Citrullinated Peptide Antibody (ACPA) on Bone Microstructure in Rheumatoid Arthritis: A HR-pQCT Study [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/effects-of-anti-citrullinated-peptide-antibody-acpa-on-bone-microstructure-in-rheumatoid-arthritis-a-hr-pqct-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/effects-of-anti-citrullinated-peptide-antibody-acpa-on-bone-microstructure-in-rheumatoid-arthritis-a-hr-pqct-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology